Project Number 1RF1AG054176-01 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for PHASE 1B FIRST-IN-PATIENT SAFETY TRIAL FOR CT1812, A NOVEL ALZHEIMER?S SYNAPTIC PROTECTION THERAPEUTIC Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator CATALANO, SUSAN M Principal Investigator First Name SUSAN Principal Investigator Last Name CATALANO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $2,410,669 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
